Radiologys Global Response to COVID Looking Back and Moving Forward Online Course, web
04/28/2024

Get insights and perspectives about radiology’s global response to the COVID-19 pandemic. Our panel will consider lessons learned and share their thoughts on what lies ahead. How will our workflows change? How can AI solutions automate chest CT analysis? How do new technology solutions help address challenges? The webinar is open to all radiologists and includes expanded content from the RSNA 2020 International Trends session where leading radiologists from around the world discussed the global impact of COVID-19.

A recording of the live webinar will be available in this course as well as RSNA’s YouTube page. within 3 business days of the webinar, held on April 29, 2021.

For ongoing education and resources, please visit RSNA’s COVID-19 resources page.

Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:

• Artificial Intelligence
• Chest Radiology
• COVID-19
• Leadership & Management
• Safety & Quality

This other activity (blended live and enduring material) is estimated to take 1 hour to complete.

Start Date: 4/29/2021
End Date for CME Eligibility/Online Expiration Date: 4/28/2024

Faculty:

• Judy Yee, MD, FACR
• Assoc. Prof. Helmut Prosch
• Richard Pitcher MBChB, FC Rad Diag(SA), PhD
• Umar Mahmood, MD, PhD
• N. Reed Dunnick, MD
• Bien Soo Tan, FRCR
• Christian J. Herold, MD

Disclosure Statements:
The ACCME requires that the RSNA, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed, please find it below:

• Judy Yee, MD, FACR: Advisory Committee, Bracco Group; Research Grant, Koninklijke Philips NV, General Electric Company.
• Assoc. Prof. Helmut Prosch : Support, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Merck & Co, Inc, Bristol-Myers Squibb Company, Novartis AG, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Siemens AG, Bayer.
• Umar Mahmood, MD, PhD : Co-founder, CytoSite Biopharma; Shareholder, CytoSite Biopharma; Consultant, CytoSite Biopharma; Grant, CytoSite Biopharma.
• Christian J. Herold, MD : Stockholder, Hologic, Inc; Research Consultant, Siemens AG, Bayer AG.

All other individuals in control of content have indicated that there are no relevant financial relationships with any commercial interests to be disclosed.

Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This other activity (blended live and enduring material) can be applied towards the ABR MOC Part 2 requirement (CME).

To earn CME credit, participants must watch the full length of the webinar, as well as complete the course evaluation.

The RSNA designates this other activity (blended live and enduring material) for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price:
Non-member Rate: $0.00
Member Rate: $0.00

Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.

RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events. Courses are best viewed on a desktop computer.